Effects of smoking cessation on b-cell function, insulin sensitivity, body weight, and appetite

European Journal of Endocrinology

Volumn 170, Issue 2, 2014, Pages 219-227

  Stadler, Marietta ^a,b,c   Tomann, Larissa ^b   Storka, Angela ^d   Wolzt, Michael ^d   Peric, Slobodan ^b   Bieglmayer, Christian ^d   Pacini, Giovanni ^e   Dickson, Suzanne L ^f   Brath, Helmut ^g   Bech, Paul ^h   Prager, Rudolf ^a,b   Korbonits, Márta ⁱ  

^a Hietzing Hospital   (Austria)

^b Karl Landsteiner Institute of Metabolic Diseases and Nephrology   (Austria)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

^e CNR   (Italy)

^f UNIVERSITY OF GOTHENBURG   (Sweden)

^g Diabetes Outpatient Clinic   (Austria)

^h HAMMERSMITH HOSPITAL   (United Kingdom)

ⁱ QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84893672611     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-13-0590     Document Type: Article

References (69)

1. Benowitz NL. The role of nicotine in smoking-related cardiovascular disease. Preventive Medicine 1997 26 412-417. (doi:10.1006/pmed.1997. 0175)
2. Villablanca AC, McDonald JM & Rutledge JC. Smoking and cardiovascular disease. Clinics in Chest Medicine 2000 21 159-172. (doi:10.1016/S0272-5231(05)70015-0)
3. Willi C, Bodenmann P, Ghali WA, Faris PD & Cornuz J. Active smoking and the risk of type 2 diabetes: a systematic review and meta-Analysis. Journal of the American Medical Association 2007 298 2654-2664. (doi:10.1001/jama.298.22.2654)
4. Pomerleau CS & Kurth CL. Willingness of female smokers to tolerate postcessation weight gain. Journal of Substance Abuse 1996 8 371-378. (doi:10.1016/S0899-3289(96)90215-1)
5. Richmond RL, Kehoe L & Webster IW. Weight change after smoking cessation in general practice. Medical Journal of Australia 1993 158 821-822.
6. Caan B, Coates A, Schaefer C, Finkler L, Sternfeld B & Corbett K. Women gain weight 1 year after smoking cessation while dietary intake temporarily increases. Journal of the American Dietetic Association 1996 96 1150-1155. (doi:10.1016/S0002-8223(96)00296-9)
7. Hofstetter A, Schutz Y, Jequier E & Wahren J. Increased 24-hour energy expenditure in cigarette smokers. New England Journal of Medicine 1986 314 79-82. (doi:10.1056/NEJM198601093140204)
8. Moffatt RJ & Owens SG. Cessation from cigarette smoking: changes in body weight, body composition, resting metabolism, and energy consumption. Metabolism 1991 40 465-470. (doi:10.1016/0026-0495(91)90225-L)
9. Facchini FS, Hollenbeck CB, Jeppesen J, Chen YD & Reaven GM. Insulin resistance and cigarette smoking. Lancet 1992 339 1128-1130. (doi:10.1016/0140-6736(92)90730-Q)
10. Fagerstrom KO & Schneider NG. Measuring nicotine dependence: a review of the Fagerstrom Tolerance Questionnaire. Journal of Behavioral Medicine 1989 12 159-182. (doi:10.1007/BF00846549)
11. Stadler M, Anderwald C, Karer T, Tura A, Kastenbauer T, Auinger M, Bieglmayer C, Wagner O, Kronenberg F, Nowotny P et al. Increased plasma amylin in type 1 diabetic patients after kidney and pancreas transplantation: a sign of impaired b-cell function? Diabetes Care 2006 29 1031-1038. (doi:10.2337/dc05- 1247)
12. Wren AM, Seal LJ, Cohen MA, Brynes AE, Frost GS, Murphy KG, Dhillo WS, Ghatei MA & Bloom SR. Ghrelin enhances appetite and increases food intake in humans. Journal of Clinical Endocrinology and Metabolism 2001 86 5992. (doi:10.1210/jc.86.12.5992)
13. Brennan IM, Feltrin KL, Nair NS, Hausken T, Little TJ, Gentilcore D, Wishart JM, Jones KL, Horowitz M & Feinle-Bisset C. Effects of the phases of the menstrual cycle on gastric emptying, glycemia, plasma GLP-1 and insulin, and energy intake in healthy lean women. American Journal of Physiology. Gastrointestinal and Liver Physiology 2009 297 G602-G610. (doi:10.1152/ajpgi.00051.2009)
14. Reed SC, Levin FR & Evans SM. Changes in mood, cognitive performance and appetite in the late luteal and follicular phases of the menstrual cycle in women with and without PMDD (premenstrual dysphoric disorder). Hormones and Behavior 2008 54 185-193. (doi:10.1016/j.yhbeh.2008.02. 018)
15. Brath H, Lasar D, Buchhausl I, Kastenbauer T & Binter E. Intensified smoking cessation for diabetic patients -preliminary results. Acta Medica Austriaca 1999 26 163-167.
16. Bischof MG, Bernroider E, Krssak M, Krebs M, Stingl H, Nowotny P, Yu C, Shulman GI, Waldhausl W & Roden M. Hepatic glycogen metabolism in type 1 diabetes after long-term near normoglycemia. Diabetes 2002 51 49-54. (doi:10.2337/diabetes.51.1.49)
17. Stadler M, Krebs M, Promintzer M, Mandl M, Bischof MG, Nowotny P, Kaestenbauer T, Luger A, Prager R & Anderwald C. Plasma obestatin is lower at fasting and not suppressed by insulin in insulin-resistant humans. American Journal of Physiology. Endocrinology and Metabolism 2007 293 E1393-E1398. (doi:10.1152/ajpendo.00330.2007)
18. Stadler M, Storka A, Theuer EA, Krebs M, Vojtassakova E, Nowotny P, Pacini G, Kastenbauer T, Luger A, Prager R et al. Adipokines in type-1 diabetes after successful pancreas transplantation: normal visfatin and retinol-binding-protein-4, but increased total adiponectin fasting concentrations. Clinical Endocrinology 2010 72 763-769. (doi:10.1111/j.1365- 2265.2009.03709.x)
19. von der Goltz C, Koopmann A, Dinter C, Richter A, Rockenbach C, Grosshans M, Nakovics H, Wiedemann K, Mann K, Winterer G et al. Orexin and leptin are associated with nicotine craving: a link between smoking, appetite and reward. Psychoneuroendocrinology 2010 35 570-577. (doi:10.1016/j.psyneuen.2009.09.005)
20. Edholm T, Degerblad M, Gryback P, Hilsted L, Holst JJ, Jacobsson H, Efendic S, Schmidt PT & Hellström PM. Differential incretin effects of GIP and GLP-1 on gastric emptying, appetite, and insulin-glucose homeostasis. Neurogastroenterology and Motility 2010 22 1191-1200. (doi:10.1111/j.1365-2982.2010.01554.x)
21. Kreymann B, Williams G, Ghatei MA & Bloom SR. Glucagon-like peptide-1 7-36: a physiological incretin in man. Lancet 1987 2 1300-1304. (doi:10.1016/S0140-6736(87)91194-9)
22. Adrian TE, Savage AP, Sagor GR, Allen JM, Bacarese-Hamilton AJ, Tatemoto K, Polak JM & Bloom SR. Effect of peptide YY on gastric, pancreatic, and biliary function in humans. Gastroenterology 1985 89 494-499.
23. Stadler M, Pacini G, Petrie J, Luger A & Anderwald C. b cell (dys)function in non-diabetic offspring of diabetic patients. Diabetologia 2009 52 2435-2444. (doi:10.1007/s00125-009-1520-7)
24. Mari A, Pacini G, Murphy E, Ludvik B & Nolan JJ. A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care 2001 24 539-548. (doi:10.2337/diacare.24.3.539)
25. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G & Quon MJ. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. Journal of Clinical Endocrinology and Metabolism 2000 85 2402-2410. (doi:10.1210/jc.85.7.2402)
26. Aubin HJ, Farley A, Lycett D, Lahmek P & Aveyard P. Weight gain in smokers after quitting cigarettes: meta-Analysis. BMJ 2012 345 e4439. (doi:10.1136/bmj.e4439)
27. Canoy D, Wareham N, Luben R, Welch A, Bingham S, Day N & Khaw KT. Cigarette smoking and fat distribution in 21,828 British men and women: a population-based study. Obesity Research 2005 13 1466-1475. (doi:10.1038/oby. 2005.177)
28. Hellerstein MK, Benowitz NL,Neese RA, Schwartz JM, Hoh R, Jacob P III, Hsieh J & Faix D. Effects of cigarette smoking and its cessation on lipid metabolism and energy expenditure in heavy smokers. Journal of Clinical Investigation 1994 93 265-272. (doi:10.1172/JCI116955)
29. RodenM, Price TB, Perseghin G, Petersen KF, Rothman DL, Cline GW& Shulman GI. Mechanism of free fatty acid-induced insulin resistance in humans. Journal of Clinical Investigation 1996 97 2859-2865. (doi:10.1172/JCI118742)
30. Neese RA, Benowitz NL, Hoh R, Faix D, LaBua A, Pun K & Hellerstein MK. Metabolic interactions between surplus dietary energy intake and cigarette smoking or its cessation. American Journal of Physiology 1994 267 E1023-E1034.
31. Ronnemaa T, Ronnemaa EM, Puukka P, Pyorala K & LaaksoM. Smoking is independently associated with high plasma insulin levels in nondiabetic men. Diabetes Care 1996 19 1229-1232. (doi:10.2337/diacare.19.11.1229)
32. Hanyu O, Yoshida J, Abe E, Hirayama S, Miyake K, Aizawa Y & Miida T. High-sensitivity CRP reflects insulin resistance in smokers. Journal of Atherosclerosis and Thrombosis 2009 16 560-567. (doi:10.5551/jat.869)
33. Attvall S, Fowelin J, Lager I, Von Schenck H & Smith U. Smoking induces insulin resistance -A potential link with the insulin resistance syndrome. Journal of Internal Medicine 1993 233 327-332. (doi:10.1111/j.1365- 2796.1993.tb00680.x)
34. Eliasson B, Attvall S, Taskinen MR & Smith U. Smoking cessation improves insulin sensitivity in healthy middle-Aged men. European Journal of Clinical Investigation 1997 27 450-456. (doi:10.1046/j.1365-2362.1997.1330680.x)
35. Bergman BC, Perreault L, Hunerdosse D, Kerege A, Playdon M, Samek AM & Eckel RH. Novel and reversible mechanisms of smokinginduced insulin resistance in humans. Diabetes 2012 61 3156-3166. (doi:10.2337/db12-0418)
36. Bruin JE, Gerstein HC, Morrison KM & Holloway AC. Increased pancreatic b-cell apoptosis following fetal and neonatal exposure to nicotine is mediated via the mitochondria. Toxicological Sciences 2008 103 362-370. (doi:10.1093/toxsci/kfn012)
37. Yoshikawa H, Hellstrom-Lindahl E & Grill V. Evidence for functional nicotinic receptors on pancreatic b cells. Metabolism 2005 54 247-254. (doi:10.1016/j.metabol.2004.08.020)
38. Woynillowicz AK, Raha S, Nicholson CJ & Holloway AC. The effect of smoking cessation pharmacotherapies on pancreatic b cell function. Toxicology and Applied Pharmacology 2012 265 122-127. (doi:10.1016/j.taap.2012.08.020)
39. Tjalve H & Popov D. Effect of nicotine and nicotine metabolites on insulin secretion from rabbit pancreas pieces. Endocrinology 1973 92 1343-1348. (doi:10.1210/endo-92-5-1343)
40. Miyata G, Meguid MM, Varma M, Fetissov SO & Kim HJ. Nicotine alters the usual reciprocity between meal size and meal number in female rat. Physiology & Behavior 2001 74 169-176. (doi:10.1016/S0031-9384(01)00540- 6)
41. Jo YH, Talmage DA & Role LW. Nicotinic receptor-mediated effects on appetite and food intake. Journal of Neurobiology 2002 53 618-632. (doi:10.1002/neu.10147)
42. Chen H, Hansen MJ, Jones JE, Vlahos R, Bozinovski S, Anderson GP & Morris MJ. Regulation of hypothalamic NPY by diet and smoking. Peptides 2007 28 384-389. (doi:10.1016/j.peptides.2006.07.034)
43. Mineur YS, Abizaid A, Rao Y, Salas R, DiLeone RJ, Gundisch D, Diano S, De Biasi M, Horvath TL, Gao XB et al. Nicotine decreases food intake through activation of POMC neurons. Science 2011 332 1330-1332. (doi:10.1126/science. 1201889)
44. Grebenstein PE, Thompson IE & Rowland NE. The effects of extended intravenous nicotine administration on body weight andmeal patterns in male Sprague-Dawley rats. Psychopharmacology 2013 228 359-366. (doi:10.1007/s00213- 013-3043-7)
45. Banks WA. The source of cerebral insulin. European Journal of Pharmacology 2004 490 5-12. (doi:10.1016/j.ejphar.2004.02.040)
46. Baskin DG, Figlewicz LD, Seeley RJ, Woods SC, Porte D Jr. & Schwartz MW. Insulin and leptin: dual adiposity signals to the brain for the regulation of food intake and body weight. Brain Research 1999 848 114-123. (doi:10.1016/S0006-8993(99)01974-5)
47. Morton GJ, Cummings DE, Baskin DG, Barsh GS & Schwartz MW. Central nervous system control of food intake and body weight. Nature 2006 443 289-295. (doi:10.1038/nature05026)
48. Tang DW, Fellows LK, Small DM & Dagher A. Food and drug cues activate similar brain regions: a meta-Analysis of functional MRI studies. Physiology & Behavior 2012 106 317-324. (doi:10.1016/j.physbeh.2012.03. 009)
49. Wahlestedt C & Reis DJ. Neuropeptide Y-related peptides and their receptors -Are the receptors potential therapeutic drug targets Annual Review of Pharmacology and Toxicology 1993 33 309-352. (doi:10.1146/annurev.pa.33. 040193.001521)
50. Higuchi H, Yang HY & Costa E. Age-related bidirectional changes in neuropeptide Y peptides in rat adrenal glands, brain, and blood. Journal of Neurochemistry 1988 50 1879-1886. (doi:10.1111/j.1471-4159.1988.tb02492.x)
51. Frankish HM, Dryden S, Wang Q, Bing C, MacFarlane IA &Williams G. Nicotine administration reduces neuropeptide Y and neuropeptide Y mRNA concentrations in the rat hypothalamus: NPY may mediate nicotine's effects on energy balance. Brain Research 1995 694 139-146. (doi:10.1016/0006-8993(95) 00834-D)
52. Li MD, Kane JK, Parker SL, McAllen K, Matta SG & Sharp BM. Nicotine administration enhances NPY expression in the rat hypothalamus. Brain Research 2000 867 157-164. (doi:10.1016/S0006-8993(00)02283-6)
53. Morris MJ, Russell AE, Kapoor V, Cain MD, Elliott JM, West MJ, Wing LM & Chalmers JP. Increases in plasma neuropeptide Y concentrations during sympathetic activation in man. Journal of the Autonomic Nervous System 1986 17 143-149. (doi:10.1016/0165-1838(86)90089-5)
54. Harle P, Straub RH, Wiest R, Mayer A, Scholmerich J, Atzeni F, Carrabba M, Cutolo M & Sarzi-Puttini P. Increase of sympathetic outflow measured by neuropeptide Y and decrease of the hypothalamic-pituitary-Adrenal axis tone in patients with systemic lupus erythematosus and rheumatoid arthritis: another example of uncoupling of response systems. Annals of the Rheumatic Diseases 2006 65 51-56. (doi:10.1136/ard.2005.038059)
55. Grassi G, Seravalle G, Calhoun DA, Bolla GB, Giannattasio C, Marabini M, Del Bo A & Mancia G. Mechanisms responsible for sympathetic activation by cigarette smoking in humans. Circulation 1994 90 248-253. (doi:10.1161/01.CIR.90.1.248)
56. Oncken CA, White WB, Cooney JL, Van Kirk JR, Ahluwalia JS & Giacco S. Impact of smoking cessation on ambulatory blood pressure and heart rate in postmenopausal women. American Journal of Hypertension 2001 14 942-949. (doi:10.1016/S0895-7061(01)02147-1)
57. Scott EM, Greenwood JP, Vacca G, Stoker JB, Gilbey SG & Mary DA. Carbohydrate ingestion, with transient endogenous insulinaemia, produces both sympathetic activation and vasodilatation in normal humans. Clinical Science 2002 102 523-529. (doi:10.1042/CS20010239)
58. Baranowska B, Wolinska-Witort E, Wasilewska-Dziubinska E, Roguski K, Martynska L & Chmielowska M. The role of neuropeptides in the disturbed control of appetite and hormone secretion in eating disorders. Neuroendocrinology Letters 2003 24 431-434.
59. Jaakkola U, Kakko T, Seppala H, Vainio-Jylha E, Vahlberg T, Raitakari OT & Kallio J. The Leu7Pro polymorphism of the signal peptide of neuropeptide Y (NPY) gene is associated with increased levels of inflammatory markers preceding vascular complications in patients with type 2 diabetes. Microvascular Research 2010 80 433-439. (doi:10.1016/j.mvr.2010.07.010)
60. Whim MD. Pancreatic b cells synthesize neuropeptide Y and can rapidly release peptide co-transmitters. PLoS ONE 2011 6 e19478. (doi:10.1371/journal. pone.0019478)
61. Schwetz TA, Ustione A & Piston DW. Neuropeptide Y and somatostatin inhibit insulin secretion through different mechanisms. American Journal of Physiology. Endocrinology and Metabolism2013 304 E211-E221. (doi:10.1152/ajpendo.00374.2012)
62. Redington K. Taste differences between cigarette smokers and nonsmokers. Pharmacology, Biochemistry, and Behavior 1984 21 203-208. (doi:10.1016/0091- 3057(84)90215-6)
63. Spring B, Pagoto S,McChargue D, Hedeker D & Werth J. Altered reward value of carbohydrate snacks for female smokers withdrawn from nicotine. Pharmacology, Biochemistry, and Behavior 2003 76 351-360. (doi:10.1016/j.pbb. 2003.08.008)
64. Stamford BA, Matter S, Fell RD & Papanek P. Effects of smoking cessation on weight gain, metabolic rate, caloric consumption, and blood lipids. American Journal of Clinical Nutrition 1986 43 486-494.
65. Levine MD, Bush T,Magnusson B, Cheng Y & Chen X. Smoking-related weight concerns and obesity: differences among normal weight, overweight, and obese smokers using a telephone tobacco quitline. Nicotine & Tobacco Research 2013 15 1136-1140. (doi:10.1093/ntr/nts226)
66. Travier N, Agudo A, May AM, Gonzalez C, Luan J, Wareham NJ, Bueno-de-Mesquita HB, van den Berg SW, Slimani N, Rinaldi S et al. Longitudinal changes in weight in relation to smoking cessation in participants of the EPIC-PANACEA study. Preventive Medicine 2012 54 183-192. (doi:10.1016/j.ypmed. 2011.09.003)
67. Williamson DF, Madans J, Anda RF, Kleinman JC, Giovino GA & Byers T. Smoking cessation and severity of weight gain in a national cohort. New England Journal of Medicine 1991 324 739-745. (doi:10.1056/NEJM199103143241106)
68. Assali AR, Beigel Y, Schreibman R, Shafer Z & Fainaru M. Weight gain and insulin resistance during nicotine replacement therapy. Clinical Cardiology 1999 22 357-360. (doi:10.1002/clc.4960220512)
69. Allen SS, Hatsukami D, Brintnell DM & Bade T. Effect of nicotine replacement therapy on post-cessation weight gain and nutrient intake: a randomized controlled trial of postmenopausal female smokers. Addictive Behaviors 2005 30 1273-1280. (doi:10.1016/j.addbeh.2005.01.003)